Houston, TX – According to filings with the U.S. Securities and Exchange Commission, Allotrope Medical has raised $4,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Albert Huang played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Allotrope Medical

We’re dedicated to the improvement of minimally invasive pelvic surgery outcomes for patients and physicians around the world. Allotrope Medical is committed to helping surgeons safely and easily identify the ureter during pelvic operations. The Houston-based company’s first product StimSite is designed to assist surgeons in the critical step of ureter identification in millions of operations performed every year. Our vision is to advance smooth muscle stimulation technology as the standard of care to help improve minimally invasive surgical outcomes and drive healthcare efficiency. We are building a dynamic team of high performing, accountable, attentive individuals looking to serve patients, partners and institutions in focused surgical specialty markets.

To learn more about Allotrope Medical, visit http://www.allotropemed.com/

Contact:
Albert Huang, President and Chief Executive Officer
832-799-8546
https://www.linkedin.com/in/albertyhuang/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved